Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

T cell development and activation in Jak3-deficient mice.

Baird AM, Thomis DC, Berg LJ.

J Leukoc Biol. 1998 Jun;63(6):669-77. Review.

PMID:
9620658
2.

The role of Jak3 in lymphoid development, activation, and signaling.

Thomis DC, Berg LJ.

Curr Opin Immunol. 1997 Aug;9(4):541-7. Review.

PMID:
9287175
3.

X-linked SCID and other defects of cytokine pathways.

Uribe L, Weinberg KI.

Semin Hematol. 1998 Oct;35(4):299-309. Review.

PMID:
9801259
4.

Targeting Janus kinase 3 in the treatment of leukemia and inflammatory diseases.

Cetkovic-Cvrlje M, Uckun FM.

Arch Immunol Ther Exp (Warsz). 2004 Mar-Apr;52(2):69-82. Review.

PMID:
15179321
6.

Interleukin 4: signalling mechanisms and control of T cell differentiation.

Paul WE.

Ciba Found Symp. 1997;204:208-16; discussion 216-9. Review.

PMID:
9107423
7.

Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development.

Leonard WJ, Shores EW, Love PE.

Immunol Rev. 1995 Dec;148:97-114. Review.

PMID:
8825284
8.

Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model.

Notarangelo LD, Giliani S, Mella P, Schumacher RF, Mazza C, Savoldi G, Rodriguez-Pérez C, Badolato R, Mazzolari E, Porta F, Candotti F, Ugazio AG.

Immunobiology. 2000 Aug;202(2):106-19. Review.

PMID:
10993286
9.

Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model.

Notarangelo LD, Giliani S, Mazza C, Mella P, Savoldi G, Rodriguez-Pérez C, Mazzolari E, Fiorini M, Duse M, Plebani A, Ugazio AG, Vihinen M, Candotti F, Schumacher RF.

Immunol Rev. 2000 Dec;178:39-48. Review.

PMID:
11213805
10.

Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.

Notarangelo LD, Mella P, Jones A, de Saint Basile G, Savoldi G, Cranston T, Vihinen M, Schumacher RF.

Hum Mutat. 2001 Oct;18(4):255-63. Review.

PMID:
11668610
11.

Is JAK3 a new drug target for immunomodulation-based therapies?

Papageorgiou AC, Wikman LE.

Trends Pharmacol Sci. 2004 Nov;25(11):558-62. Review.

PMID:
15491777
12.

Disruption of cytokine signaling in lymphoid development: unique contributions of the common cytokine gamma chain and the Jak3 kinase.

Eynon EE, Kuida K, Flavell RA.

J Interferon Cytokine Res. 1996 Sep;16(9):677-84. Review. No abstract available.

PMID:
8887051
13.

Review of T-cell activation: impact of Janus kinase 3 inhibition.

Nashan B.

Transplantation. 2003 Jun 15;75(11):1783-5. Review. No abstract available.

PMID:
12822564

Supplemental Content

Support Center